Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

A male with aromatase deficiency improved bone health with estradiol treatment.

No link found between specific genes and female pattern hair loss.

HLD10 can include increased body hair and Mongolian spots.

A genetic mutation in the DCAF17 gene caused Woodhouse-Sakati syndrome in a Chinese patient from a related family.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

A child has a rare hair and skin disorder due to specific gene variants, suggesting broader genetic testing is needed.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Gene sequencing is crucial for diagnosing Junctional epidermolysis bullosa.

Hedgehog signaling controls hair follicle development and can affect skin cancer growth.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The assay effectively detects hormonal activity of certain chemicals.

Targeting the TNFRSF1B gene may help treat hair loss.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

Changes in the HR gene have influenced hair growth and may lead to hair loss conditions in humans.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Researchers found a new mutation in the LIPH gene of a woman with a rare hair condition.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.